Blau Farmacêutica S.A. (BVMF:BLAU3)
Brazil flag Brazil · Delayed Price · Currency is BRL
12.79
-0.69 (-5.12%)
Dec 5, 2025, 5:40 PM GMT-3

Blau Farmacêutica Company Description

Blau Farmacêutica S.A., a pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.

Its products cover various areas, such as immunology, hematology, oncology, nephrology, infectology, and anesthesiology.

The company offers uterine stimulator, antirheumatic, anaesthetics, antibiotics, feminine health care, biopharmaceuticals, oncologicals, hospital products, antivirals and antiretrovirals, biológicos, acid pump inhibitor, hemoderivatives, antithrombotic, and thrombolytics products.

Blau Farmacêutica S.A. was incorporated in 1987 and is headquartered in Cotia, Brazil.

Blau Farmacêutica S.A.
Country Brazil
Founded 1987
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,900
CEO Marcelo Hahn

Contact Details

Address:
Rodovia Raposo Tavares
Cotia, 06705-030
Brazil
Phone 55 80 0701 6399
Website blau.com

Stock Details

Ticker Symbol BLAU3
Exchange Brazil Stock Exchange
Fiscal Year January - December
Reporting Currency BRL
ISIN Number BRBLAUACNOR8
SIC Code 2836

Key Executives

Name Position
Marcelo Rodolfo Hahn Founder, Controller, Chief Executive Officer and Deputy Chairman
Douglas Leandro Rodrigues Administrative, Financial and Investor Relations Director
Vanderlei Schiavo Chief Technology, Digital Transformation and Innovation Officer
Roberto Altieri Chief Legal Officer
Ana Luzia Marques Ivanov Chief People, Management and ESG Officer
Roberto Carlos de Campos Morais Chief M&A and Operations (USA and Europe) Officer and Director
Eliza Yukie Saito Chief Quality Officer
Eliana Sueco Tibana Samano Chief Medical Officer
Amaro Arialdo de Souza Junior Chief Business Unit Officer of Onco-Hematology and Specialties
Milton Zanetti Rizo Chief Industrial Operations Officer